AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news

Forecasts

5 stories about Forecasts
CTech Forecast Conference Moran Alon

Pictet Wealth Management: “We're really, really focused on AI in 2024”

31.12.23|Ariela Karmel
CEO of Pictet Wealth Management’s Israel branch Moran Alon spoke to CTech at Calcalist’s 2024 Forecasts event about her outlook for the Israeli economy in 2024.
ועידת התחזיות 2022 מימין ניר צוק מייסד Palo Alto Networks ו אריק שטילמן מנכ"ל ושותף מייסד Rapyd

Nir Zuk faces criticism after saying high-earning techies should be heavily taxed

30.12.21|CTech
The founder of Palo Alto suggested increasing taxes for high-earning tech employees in order to bridge the gaps in Israeli society, but CEO of Rapyd Arik Shtilman called him out, claiming taxes are one of the reasons for the sector’s workforce shortage
‍ועידת התחזיות 2022 יואל אסתרון מו"ל כלכליסט

Wanted: A booster of humbleness for 2022

30.12.21|Yoel Esteron
“Let's be more humble, not only in our pretension to make forecasts, but also in life itself,” says Calcalist Publisher Yoel Esteron
תל אביב רמת גן מבט על מלמעלה

IMF Cuts Israel's Growth Forecast for 2019, Again

16.10.19|Adrian Filut
The International Monetary Fund lowered its growth forecast for Israel to 3.1%, after lowering it from 3.5% to 3.3% in April. It also cut its global growth forecast for this year, lowering it to 3% from the 3.2% it forecasted in July—the lowest forecast in a decade
מנכ"ל טבע החדש קור שולץ 2

Generic Dependence Threatens Teva’s Ability to Haul Debt Load

05.11.17|Dror Reich and Lilach Baumer
Teva’s stock price dropped 18.7% last week after the company lowered its annual forecasts. On Friday, S&P changed the company’s outlook to negative